Economy

Regeneron Pharmaceuticals, Inc. (REGN) Shares Sold by Sumitomo Life Insurance Co

Rice Energy Inc now has $6.01B valuation. At the close of regular trading, its last week's stock price volatility was 0.84% which for the month reaches 0.95%. About 305,630 shares traded. It has underperformed by 68.69% the S&P500. Regeneron Pharmaceuticals Inc. had 91 analyst reports since July 28, 2015 according to SRatingsIntel. Finally, Canaccord Genuity set a $522.00 price target on shares of Regeneron Pharmaceuticals and gave the company a "buy" rating in a report on Friday, July 28th. The stock now has a consensus rating of Hold and an average target price of $487.80. About 990,334 shares traded or 23.94% up from the average. It has outperformed by 0.70% the S&P500.

Regeneron Pharmaceuticals, Inc.is a biopharmaceutical firm that discovers, invents, develops, makes and commercializes medicines for the treatment of serious medical conditions. The stock has a market capitalization of $46.26 billion, a P/E ratio of 43.77 and a beta of 1.62. The Company commercializes medicines for eye diseases, high low-density lipoprotein (LDL) cholesterol, and an inflammatory condition and have product candidates in development in other areas, including rheumatoid arthritis, asthma, atopic dermatitis, pain, cancer, and infectious diseases. It has a 56.65 P/E ratio. The Company's marketed products include EYLEA (aflibercept) Injection, Praluent (alirocumab) Injection, ARCALYST (rilonacept) Injection for Subcutaneous Use, Kevzara (sarilumab) Solution for Subcutaneous Injection and ZALTRAP (ziv-aflibercept) Injection for Intravenous Infusion. $4.01M worth of Regeneron Pharmaceuticals Inc (NASDAQ:REGN) was sold by STAHL NEIL on Wednesday, June 14. BlackRock Inc. now owns 6,188,267 shares of the biopharmaceutical company's stock valued at $3,039,305,000 after buying an additional 41,406 shares during the period. Robert W. Baird lowered shares of Regeneron Pharmaceuticals from a "neutral" rating to an "underperform" rating and set a $408.00 price target on the stock.in a report on Tuesday, August 1st. The insider VAGELOS P ROY sold 9,295 shares worth $4.26 million. BROWN MICHAEL S sold 3,000 shares worth $1.35M. Wall Street experts also assign a $498.26 price target on Regeneron Pharmaceuticals, Inc., pointing towards a 15.14% rally from current levels. (REGN). The consensus rating is 2.3, suggesting the market has given up on the stock. Therefore 46% are positive. On average, equities research analysts anticipate that Regeneron Pharmaceuticals will post $14.94 earnings per share for the current year. The firm earned "Buy" rating on Thursday, August 3 by BTIG Research. The firm has "Outperform" rating given on Friday, February 12 by BMO Capital Markets. The stock has "Outperform" rating by RBC Capital Markets on Thursday, February 11. Chardan Capital Markets downgraded it to "Neutral" rating and $565 target in Monday, August 31 report. As per Friday, July 21, the company rating was maintained by Piper Jaffray.

Investors might also notice that three month ago the Buy recommendations (27) outnumbered Sell recommendations (1).

Since May 1, 2017, it had 0 buys, and 2 sales for $1.66 million activity. It is positive, as 42 investors sold REGN shares while 157 reduced holdings. 59 funds opened positions while 122 raised stakes. Lmr Prtnrs Llp holds 0.12% or 3,790 shares. Ftb Advisors reported 166 shares stake. Vetr upgraded Regeneron Pharmaceuticals Inc (NASDAQ:REGN) rating on Friday, August 21. Eqis Mngmt Inc stated it has 3,179 shares or 0.09% of all its holdings.

Regeneron Pharmaceuticals (NASDAQ:REGN) last posted its quarterly earnings results on Thursday, August 3rd. About shares traded. Regeneron Pharmaceuticals Inc (NASDAQ:REGN) has risen 17.40% since October 24, 2016 and is uptrending. Atika Capital Ltd holds 110,000 shares or 3.89% of its portfolio. 160,207 were reported by Guggenheim Ltd Com. Principal Fincl Group Inc Inc stated it has 115,201 shares. Geode Cap Mgmt Ltd Limited Liability Company, a Massachusetts-based fund reported 23,048 shares. (NASDAQ REGN) traded down 0.9151% during mid-day trading on Tuesday, hitting $428.7999.

Investors sentiment increased to 1.38 in 2017 Q2. Its down 0.13, from 0.92 in 2017Q1.

A number of institutional investors have recently added to or reduced their stakes in the stock. 47 funds opened positions while 62 raised stakes. Wealthtrust reported 9 shares. Morgan Stanley holds 0% of its portfolio in Evoke Pharma Inc (NASDAQ:EVOK) for 3,509 shares. Overbrook Management holds 0.13% of its portfolio in Regeneron Pharmaceuticals Inc (NASDAQ:REGN) for 1,258 shares. It also upped United Parcel Service Inc (NYSE:UPS) stake by 11,568 shares and now owns 19,135 shares. D E Shaw And invested in 0.21% or 4.86M shares. Atria Limited Liability Company invested in 0.04% or 1,168 shares. Employees Retirement Of Texas reported 106,000 shares. Jennison Associates Ltd Liability accumulated 1.29M shares. The number of shares now owned by investors are 109.12 mln. Eaton Vance reported 0.01% of its portfolio in Rice Energy Inc (NYSE:RICE). Los Angeles & Equity Research Inc holds 0.01% in Regeneron Pharmaceuticals Inc (NASDAQ:REGN) or 3,981 shares. Whetstone holds 4.71% in Rice Energy Inc (NYSE:RICE) or 316,520 shares. Peak6 Investments Limited Partnership, a Illinois-based fund reported 135,966 shares. Veritable LP invested in 0.02% or 9,028 shares.

Rock Springs Capital Management Lp decreased Walgreens Boots Alliance Inc stake by 75,000 shares to 86,000 valued at $6.74 million in 2017Q2. The firm owned 5,402 shares of the biopharmaceutical company's stock after selling 698 shares during the quarter. Toll Brothers Inc (NYSE:TOL) was raised too.



Like this

Latest


25 October 2017
Sergio Aguero to captain Manchester City against Wolverhampton Wanderers
But second-tier Bristol City hit back through goals from Matt Taylor, Milan Djuric, Joe Bryan and Callum O'Dowda. But City finally got an edge in the shootout as Claudio Bravo saved Alfred N'Diaye and Conor Coady efforts.

25 October 2017
Stock Upsurging Yielding Gains in Session ICICI Bank Limited (NYSE:IBN)
The stock is now moving below its 20-Day Simple Moving Average of -4.97% with a 50-Day Simple Moving Average of -9.92 percent. CAPROCK Group Inc. purchased a new position in ICICI Bank Limited in the 2nd quarter valued at approximately $107,000.

25 October 2017
Leeds United: Boss Christiansen has no complaints as Whites exit Carabao Cup
Leicester City winger Demarai Gray has explained that his side are aware of Leeds United's resilient nature, ahead of the teams' meeting in the EFL Cup tonight.

25 October 2017
Monro, Inc. (NASDAQ:MNRO) To Report Earnings
Nisa Investment Advisors LLC's holdings in Monro Muffler Brake were worth $269,000 at the end of the most recent quarter. Following the transaction, the vice president now owns 58,000 shares in the company, valued at approximately $2,785,160.

25 October 2017
Is CONSOL Energy Inc. (NYSE:CNX) Undervalued?
Earnest Partners Llc increased Synopsys Inc (NASDAQ:SNPS) stake by 10,286 shares to 668,031 valued at $48.72 million in 2017Q2. It also reduced Gray Television Inc (NYSE:GTN) stake by 32,948 shares and now owns 607,907 shares.

25 October 2017
Uber Driver Injured in Bay Area Gun Battle
Unfortunately the driver was struck, but fortunately suffered non-life threatening injuries. It is not known why they were shot although the driver is was not the original target.

25 October 2017
Investors await Trump's Federal Reserve chair pick
The U.S. dollar climbed against most major currencies on Tuesday as market attention turned to who will be the next head of the U.S.

25 October 2017
Trading Monitor: PPOH Line Above Zero for Polaris Industries Inc (PII)
Polaris Industries ( PII ) reported third quarter EPS of $1.46 Tuesday morning, up from $0.50 in the prior year period. The company has a market capitalization of $6.69 billion, a price-to-earnings ratio of 44.72 and a beta of 1.31.

25 October 2017
Voice of 'The Lion King's Rafiki, Robert Guillaume, passes away
He received a Tony Award nomination in 1976 for his performance as Nathan Detroit in an all-black production of Guys and Dolls . Actor Robert Guillaume pose for Pictures at the 2000 Essence Awards held at Radio City Music Hall in New York City.

25 October 2017
The Travelers Companies, Inc. (TRV) Given New $145.00 Price Target at Argus
Following the completion of the sale, the insider now owns 253,744 shares in the company, valued at approximately $32,134,140.16. It now has negative earnings. 01/17/2017 - The Travelers Companies, Inc . was upgraded to "outperform" by analysts at Macquarie.



Recommended